ET AL Phillip Frost MD - Director, 10%+ Owner at Cocrystal Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
COCP on Nasdaq
All Insider Reports
All Insider Reports

ET AL Phillip Frost MD - trading volume in the past year for Cocrystal Pharma, Inc.

Holdings reported by ET AL Phillip Frost MD for Cocrystal Pharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,888,551 $1,785,813 $0.9456 06 Feb 2026 By Frost Gamma Investments Trust
Warrants 719,426 $1,000,002 $1.39 28 Oct 2025 By Frost Gamma Investments Trust Common Stock
Common Stock 27,100 $26,528 $0.9789 06 Feb 2026 Direct
Stock Options (Right to Buy) 24,615 09 Jan 2026 Direct Common Stock

Transactions reported by ET AL Phillip Frost MD for Cocrystal Pharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.